Finally, in the functional assessment of anakinra effects in the Adriamycin-nephropathy model of FSGS, anakinra did not significantly alter the albumin:creatinine ratio (Fig 2D). This evidence concerns the gene ALB and focal segmental glomerulosclerosis.